<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">18633352</PMID>
        <DateCompleted>
            <Year>2008</Year>
            <Month>09</Month>
            <Day>23</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>12</Month>
            <Day>01</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-4687</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>454</Volume>
                    <Issue>7208</Issue>
                    <PubDate>
                        <Year>2008</Year>
                        <Month>Aug</Month>
                        <Day>28</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature</Title>
                <ISOAbbreviation>Nature</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Acetylcholine contributes through muscarinic receptors to attentional modulation in V1.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1110-4</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/nature07141</ELocationID>
            <Abstract>
                <AbstractText>Attention exerts a strong influence over neuronal processing in cortical areas. It selectively increases firing rates and affects tuning properties, including changing receptive field locations and sizes. Although these effects are well studied, their cellular mechanisms are poorly understood. To study the cellular mechanisms, we combined iontophoretic pharmacological analysis of cholinergic receptors with single cell recordings in V1 while rhesus macaque monkeys (Macaca mulatta) performed a task that demanded top-down spatial attention. Attending to the receptive field of the V1 neuron under study caused an increase in firing rates. Here we show that this attentional modulation was enhanced by low doses of acetylcholine. Furthermore, applying the muscarinic antagonist scopolamine reduced attentional modulation, whereas the nicotinic antagonist mecamylamine had no systematic effect. These results demonstrate that muscarinic cholinergic mechanisms play a central part in mediating the effects of attention in V1.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Herrero</LastName>
                    <ForeName>J L</ForeName>
                    <Initials>JL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Neuroscience, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roberts</LastName>
                    <ForeName>M J</ForeName>
                    <Initials>MJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Delicato</LastName>
                    <ForeName>L S</ForeName>
                    <Initials>LS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gieselmann</LastName>
                    <ForeName>M A</ForeName>
                    <Initials>MA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dayan</LastName>
                    <ForeName>P</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thiele</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>070380</GrantID>
                    <Agency>Wellcome Trust</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>BBS/B/09325</GrantID>
                    <Agency>Biotechnology and Biological Sciences Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>070380/Z/03/Z</GrantID>
                    <Agency>Wellcome Trust</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2008</Year>
                <Month>07</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nature</MedlineTA>
            <NlmUniqueID>0410462</NlmUniqueID>
            <ISSNLinking>0028-0836</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018680">Cholinergic Antagonists</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018727">Muscarinic Antagonists</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018733">Nicotinic Antagonists</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D011950">Receptors, Cholinergic</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D011976">Receptors, Muscarinic</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>6EE945D3OK</RegistryNumber>
                <NameOfSubstance UI="D008464">Mecamylamine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>DL48G20X8X</RegistryNumber>
                <NameOfSubstance UI="D012601">Scopolamine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>N9YNS0M02X</RegistryNumber>
                <NameOfSubstance UI="D000109">Acetylcholine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000109" MajorTopicYN="N">Acetylcholine</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001288" MajorTopicYN="N">Attention</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018680" MajorTopicYN="N">Cholinergic Antagonists</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008253" MajorTopicYN="N">Macaca mulatta</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008464" MajorTopicYN="N">Mecamylamine</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018727" MajorTopicYN="N">Muscarinic Antagonists</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018733" MajorTopicYN="N">Nicotinic Antagonists</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011950" MajorTopicYN="N">Receptors, Cholinergic</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011976" MajorTopicYN="N">Receptors, Muscarinic</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012601" MajorTopicYN="N">Scopolamine</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <OtherID Source="NLM">UKMS4529</OtherID>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2008</Year>
                <Month>04</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2008</Year>
                <Month>06</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2008</Year>
                <Month>7</Month>
                <Day>18</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2008</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2008</Year>
                <Month>7</Month>
                <Day>18</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">18633352</ArticleId>
            <ArticleId IdType="pii">nature07141</ArticleId>
            <ArticleId IdType="doi">10.1038/nature07141</ArticleId>
            <ArticleId IdType="pmc">PMC2666819</ArticleId>
            <ArticleId IdType="mid">UKMS4529</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Neurosci. 2002 Mar 1;22(5):1905-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11880520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2001 Feb 23;291(5508):1560-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11222864</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2003 Jan 23;421(6921):370-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12540901</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscience. 2004;126(2):257-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15207343</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Comp Neurol. 1985 Dec 1;242(1):1-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3841131</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1988 Apr 15;240(4850):338-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3353728</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1996 Aug 8;382(6591):539-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8700227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurophysiol. 1997 Jan;77(1):24-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9120566</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychopharmacology (Berl). 1997 Aug;132(4):324-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9298509</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vision Res. 1997 Dec;37(24):3559-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9425531</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Neurosci. 2006 Sep;9(9):1156-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16906153</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Comp Neurol. 2006 Nov 1;499(1):49-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16958109</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci Methods. 2006 Dec 15;158(2):207-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16843532</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2007 May 23;27(21):5633-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17522308</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2007 Oct 4;56(1):141-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17920021</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Neurosci. 2007 Nov;10(11):1483-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17906622</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2007 Nov 21;56(4):701-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18031686</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuropsychopharmacology. 2008 Mar;33(4):913-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17534379</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1998 Sep 24;395(6700):376-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9759726</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 1999 Mar 1;19(5):1736-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10024360</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res Brain Res Rev. 2005 Feb;48(1):98-111</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15708630</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuropsychopharmacology. 2005 Apr;30(4):810-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15668726</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscience. 2005;132(2):347-59</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15802188</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2005 May 19;46(4):681-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15944135</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Comp Neurol. 2005 Dec 5;493(1):140-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16254988</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 2005 Nov 23;25(47):11023-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16306415</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurophysiol. 2000 Mar;83(3):1536-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10712478</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res Brain Res Rev. 2000 Mar;31(2-3):295-301</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10719156</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2000 Jun;26(3):703-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10896165</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Neurosci. 2002 Mar;3(3):201-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11994752</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>